Qi Wang1, Jianping Zheng2, Yufeng Ren2, Hui Xu1. 1. Department of Mammary Health Care, Liaocheng Dongchangfu Maternal and Child Health Hospital Liaocheng 252000, Shandong Province, China. 2. Department of Ultrasound, Dongchangfu Hospital of Traditional Chinese Medicine Liaocheng 252000, Shandong Province, China.
Abstract
OBJECTIVE: To explore the effects of trans-areolar resection and minimally invasive mammotome biopsy on therapeutic effect. METHODS: A total of 131 patients with breast fibroadenoma were selected as the research subjects. Among them, 58 patients were treated by trans-areolar resection and included in group A (GA), and 73 patients were treated by minimally invasive mammotome biopsy and included in group B (GB). The changes of blood pressure, intraoperative blood loss and incision length in patients were detected before anesthesia, during resection and after operation. The pain score and operation time of patients were analyzed. The incidence of postoperative complications and the therapeutic effect were compared in the two groups. The Vancouver Scar Scale (VSS) was used to assess scar condition of patients in the two groups, and the lower the score, the more normal the skin. After operation, the satisfaction with breast appearance was assessed, and the quality of life was compared between the two groups. RESULTS: During resection, DBP and SBP indexes of blood pressure in GA were lower than GB . The intraoperative blood loss in GA was greater than GB, and the incision length was also greater than GB. The VAS pain score in GA was higher than GB (P<0.05), and operation time was also longer than GB. The incidence of complications in GB was significantly lower than GA. The total effective rate in GB was significantly higher than GA. The scar score in GA was significantly higher than GB. The satisfaction in GB was significantly higher than GA, and the quality of life in GB was higher than GA. All P<0.05. CONCLUSION: Compared with trans-areolar resection, minimally invasive mammotome biopsy has a better therapeutic effect on patients with breast fibroadenoma, and it can improve their quality of life more significantly. AJTR
OBJECTIVE: To explore the effects of trans-areolar resection and minimally invasive mammotome biopsy on therapeutic effect. METHODS: A total of 131 patients with breast fibroadenoma were selected as the research subjects. Among them, 58 patients were treated by trans-areolar resection and included in group A (GA), and 73 patients were treated by minimally invasive mammotome biopsy and included in group B (GB). The changes of blood pressure, intraoperative blood loss and incision length in patients were detected before anesthesia, during resection and after operation. The pain score and operation time of patients were analyzed. The incidence of postoperative complications and the therapeutic effect were compared in the two groups. The Vancouver Scar Scale (VSS) was used to assess scar condition of patients in the two groups, and the lower the score, the more normal the skin. After operation, the satisfaction with breast appearance was assessed, and the quality of life was compared between the two groups. RESULTS: During resection, DBP and SBP indexes of blood pressure in GA were lower than GB . The intraoperative blood loss in GA was greater than GB, and the incision length was also greater than GB. The VAS pain score in GA was higher than GB (P<0.05), and operation time was also longer than GB. The incidence of complications in GB was significantly lower than GA. The total effective rate in GB was significantly higher than GA. The scar score in GA was significantly higher than GB. The satisfaction in GB was significantly higher than GA, and the quality of life in GB was higher than GA. All P<0.05. CONCLUSION: Compared with trans-areolar resection, minimally invasive mammotome biopsy has a better therapeutic effect on patients with breast fibroadenoma, and it can improve their quality of life more significantly. AJTR
Authors: Alexander C Flint; Carol Conell; Xiushui Ren; Nader M Banki; Sheila L Chan; Vivek A Rao; Ronald B Melles; Deepak L Bhatt Journal: N Engl J Med Date: 2019-07-18 Impact factor: 91.245
Authors: Camila Maria Simplicio-Revoredo; Renato de Oliveira Pereira; Mariella de Almeida Melo; Pedro Vitor Lopes-Costa; Paulo de Tarso Moura-Borges; Emerson Brandão Sousa; Fidelis Manes Neto; Viriato Campelo; Ione Maria Ribeiro Soares-Lopes; Maria da Conceição Barros-Oliveira; Cleciton Braga Tavares; Alesse Ribeiro Dos Santos; Camila Guedes Borges de Araújo; Eid Gonçalves Coelho; Larysse Cardoso Campos-Verdes; Aldenora Oliveira do Nascimento-Holanda; Jackeline Lopes Viana; Maria Liduina Meneses Bezerra-Chaves; Rodrigo José de Vasconcelos-Valença; Lina Gomes Dos Santos; Lauro Rodolpho Soares-Lopes; André Luiz Pinho-Sobral; Luiz Henrique Gebrim; Benedito Borges da Silva Journal: Oncotarget Date: 2020-05-05
Authors: Elina Stoffel; Anton S Becker; Moritz C Wurnig; Magda Marcon; Soleen Ghafoor; Nicole Berger; Andreas Boss Journal: Eur J Radiol Open Date: 2018-09-24
Authors: Luana Mota Martins; Carla Solange de Melo Escorcio Dourado; Larysse Maira Campos-Verdes; Fabiane Araújo Sampaio; Camila Maria Simplício Revoredo; Danylo Rafhael Costa-Silva; Maria da Conceição Barros-Oliveira; Elmo de Jesus Nery Junior; Lucia Maria do Rego-Medeiros; Luiz Henrique Gebrim; Francisco Adelton Alves-Ribeiro; Gilmara Péres Rodrigues; Diego Cipriano Chagas; Dilina do Nascimento Marreiro; Benedito Borges da Silva Journal: Oncotarget Date: 2019-12-03